A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer
- 1 October 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (11) , 1888-1892
- https://doi.org/10.1016/0959-8049(96)00191-8
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Progestins in Breast Cancer Treatment: A ReveiwActa Oncologica, 1992
- A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Endocrine Therapy of Advanced Breast CancerActa Oncologica, 1988
- Megestrol acetate therapy for advanced breast cancer.Journal of Clinical Oncology, 1985
- Randomized clinical trial of megestrol acetate versus tamoxifen in paramenopausal or castrated women with advanced breast cancerAmerican Journal of Clinical Oncology, 1982
- Some Methods for Strengthening the Common χ 2 TestsPublished by JSTOR ,1954